← All news
Markets
Royalty Pharma expects modest return despite pelacarsen trial failure
Covered by 1 outlet
All coverage · 3 articles
Investing.com Canada
·Sep 4, 23:10 UTC
Royalty Pharma expects modest return despite pelacarsen trial failure
Investing.com UK
·Sep 4, 23:10 UTC
Royalty Pharma expects modest return despite pelacarsen trial failure
Investing.com News
·Sep 4, 23:08 UTC